Postoperative pulmonary complication in patients with resolved Covid-19
Not Applicable
Recruiting
- Conditions
- Codes for special purposes
- Registration Number
- KCT0007530
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
? Adults 18 years of age or older
? Patients scheduled for major non-cardiac surgery
Exclusion Criteria
? Patients who are intubated before surgery
? Patients without chest x-ray before surgery
? Active corona-infected patients
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative pulmonary complications
- Secondary Outcome Measures
Name Time Method Pulmonary complications according to the time of diagnosis and the duration of surgery
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link resolved SARS-CoV-2 infection to postoperative pulmonary complications in non-cardiac surgery?
How does the risk of postoperative acute respiratory distress syndrome (ARDS) compare between resolved COVID-19 patients and non-infected controls in observational studies?
Which biomarkers (e.g., IL-6, surfactant proteins) predict postoperative pulmonary complications in KCT0007530 participants with prior SARS-CoV-2 infection?
What adverse respiratory events are reported in non-cardiac surgery following resolved COVID-19, and how are they managed clinically?
How do corticosteroid or anticoagulant therapies influence postoperative pulmonary outcomes in patients with resolved SARS-CoV-2 infection?